Medium Spiny Neurons (MSNs) represent a prominent neuronal subtype primarily found in the striatum, a key component of the brain's basal ganglia. Characterized by their distinctive morphology and sensitivity to dopamine, MSNs play a central role in motor control, reward processing, and habit formation. They are classified into two main subtypes based on their projection targets: those projecting to the internal globus pallidus (direct pathway) and those projecting to the external globus pallidus via the indirect pathway. The balance between these pathways is crucial for modulating movement and preventing unwanted actions. MSNs receive input from various brain regions, including the cortex and thalamus, forming complex neural circuits. Dysregulation of MSN activity has been implicated in neurodegenerative disorders such as Parkinson's disease and Huntington's disease. Studying the physiology and connectivity of medium spiny neurons provides valuable insights into the neural mechanisms underlying motor control and reward-based learning. Ongoing research aims to unravel the intricacies of MSN function, exploring potential therapeutic targets for neurological conditions associated with basal ganglia dysfunction.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation